Matthew Hofeldt, MD
Surgery · Huntington, WVNPI 1730236217
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 74.1% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $2,326 and has fallen 96.6% since, to $80 in 2025.
Across 100 payments — averaging $38.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Takeda Pharmaceuticals U.S.A., Inc.$189
- Davol Inc.$137
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$69
- AbbVie$61
- Integra Lifesciences Corporation$59
- plus $482 from 17 others
What the payments were for
- Speaking & faculty fees$1504%
- Travel & lodging$1,53940%
- Food & beverage$2,15156%
- Gifts$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 52 | $2,854 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $189 |
| Davol Inc. | 4 | $137 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| AbbVie(2 entities) | 3 | $61 |
| Integra Lifesciences Corporation | 3 | $59 |
| Organogenesis Inc. | 2 | $51 |
| Vifor Pharma, Inc. | 4 | $49 |
| Amgen | 3 | $44 |
| Johnson & Johnson | 3 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Mallinckrodt Enterprises LLC | 2 | $36 |
| AstraZeneca(2 entities) | 2 | $33 |
| Vertex | 1 | $31 |
| Conmed Corporation | 1 | $29 |
| Esperion Therapeutics, Inc. | 2 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Scpharmaceuticals Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,826
- GATTEX$150
How this compares
$3,851 in reported general payments places this provider in the 70th percentile of 162 surgery providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 202 | $974 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 12 | $926 |
| Ondansetron Hcl | 51 | $412 |
| Ibuprofen | 55 | $304 |
| Pantoprazole Sodium | 21 | $143 |
| Omeprazole | 27 | $135 |
| Neomycin Sulfate | 12 | $78 |
| Metronidazole | 13 | $32 |
| Tramadol Hcl | 15 | $26 |
Paid to pharmacies, not to this prescriber.
Other surgery in Huntington
- Farzad AmiriHuntington$66K
- Semeret MunieHuntington$9K
- Matthew KrantzHuntington$7K
- Paul BownHuntington$7K
- Agon KajmolliHuntington$7K
- Stephen WilsonHuntington$5K
- Juan SanabriaHuntington$4K
- Andrew WeaverHuntington$3K
- Jake RubensteinHuntington$3K
- Darren NeaseCharleston$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.